<- Go Home

Fagron NV

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort; and Cleoderm, a topical cream used for the compounding of personalized dermatological treatments. It also offers education and professional development of prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Market Cap

EUR 1.4B

Volume

56.2K

Cash and Equivalents

EUR 115.0M

EBITDA

EUR 146.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 395.7M

Profit Margin

45.38%

52 Week High

EUR 20.15

52 Week Low

EUR 15.14

Dividend

1.86%

Price / Book Value

2.73

Price / Earnings

17.09

Price / Tangible Book Value

61.55

Enterprise Value

EUR 1.6B

Enterprise Value / EBITDA

10.28

Operating Income

EUR 130.0M

Return on Equity

16.65%

Return on Assets

7.77

Cash and Short Term Investments

EUR 115.9M

Debt

EUR 386.7M

Equity

EUR 505.4M

Revenue

EUR 872.0M

Unlevered FCF

EUR 49.4M

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches